Navigation Links
UNIAPAC Foundation Think Tank in Paris selects Renova Therapeutics CEO and Co-founder as keynote speaker for annual meeting

SAN DIEGO, March 7, 2017 /PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes, today announced that the company's CEO and Co-founder, Jack W. Reich, Ph.D., has been selected as a keynote speaker for the prestigious UNIAPAC Foundation Think Tank meeting on March 17, 2017, in Paris.

The aim of this annual meeting is to lead a candid and open debate among academics, business leaders and distinguished guests, to provide insights on the main socioeconomic challenges of the 21st century. The meeting brings together 24 high-level attendees and includes a full set of presentations and dialogue sessions.

Dr. Jack W. Reich, CEO & Co-founder of Renova Therapeutics
Dr. Jack W. Reich, CEO & Co-founder of Renova Therapeutics
 (PRNewsFoto/Renova Therapeutics)
(PRNewsFoto/Renova Therapeutics)...

A pioneer in the field, Dr. Reich will be speaking on the social, economic and healthcare delivery implications of gene therapy.

"I'm honored to engage on the topic of gene therapy with bright minds who are dedicated to finding solutions to some of the world's greatest challenges," says Dr. Reich. "Our mission at Renova Therapeutics – to create transformational therapies that treat the world's most prevalent diseases – fits closely with the goals of UNIAPAC and its foundation. We're focused on treating chronic diseases that have a debilitating impact on hundreds of millions of people worldwide – and doing so by potentially reversing the disease process, rather than treating symptoms. Diminishing these major threats to global health would have tremendous socioeconomic impact."

Founded in 1931, UNIAPAC is an ecumenical union that groups together Christian Business Leader associations in 40 countries in Europe, Latin America, Africa and Asia. UNIAPAC represents more than 30,000 active business executives working in various leading sectors of the world economy. The organization's goal is to promote a vision and deployment of Corporate Social Responsibility focused on the human person, with a view of bringing about change in business attitudes toward more responsible and sustainable economic, social and human progress.

The UNIAPAC Foundation was created in 2010 with the intent to actively assist UNIAPAC National Associations in their local initiatives and support their activities at an international level. The foundation is a key facilitator in UNIAPAC's continuous dialogue with all men and women of goodwill who are interested in ensuring the rightful place of the human person in the economy.

Dr. Reich will lead one of four panels at the foundation's think tank meeting.

About Renova Therapeutics
Renova Therapeutics is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. The first indications the company is pursuing are gene therapy treatments for congestive heart failure (CHF) and type 2 diabetes, two of the most common and devastating chronic diseases in the world. The company's lead product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in millions of patients with CHF. The company's product pipeline also includes a groundbreaking gene therapy in preclinical stage for sufferers of type 2 diabetes, as well as a peptide infusion therapy for the treatment of acute decompensated heart failure. Renova Therapeutics was founded in 2009 and is led by an experienced management team in biopharmaceuticals and gene therapy. For additional information about the company, please visit


To view the original version on PR Newswire, visit:

SOURCE Renova Therapeutics
Copyright©2017 PR Newswire.
All rights reserved

Related biology technology :

1. UCB, Inc. and the Epilepsy Foundation of Georgia Launch EFWorks to Help Georgians with Epilepsy Find Employment
2. New Jersey Health Foundation Awards $1.1 Million to Advance Research Throughout NJ
3. Foundation for Food and Agriculture Research Seeks Early Career Nominees for New Innovator in Food and Agriculture Research Award
4. Foundation for Food and Agriculture Research Congratulates Edward Buckler, First Recipient of Prestigious NAS Prize for Extraordinary Contribution to Food and Agriculture
5. Caris Life Sciences and the Lustgarten Foundation Collaborate to Support Immunotherapy Clinical Trial for Pancreatic Cancer
6. Symbios Announces National Science Foundation SBIR Phase IIB Award to Commercialize Plasma Oxidation Technology
7. ACRES and Task Force Dagger Foundation Partner to Improve Special Operations Forces Health
8. Thanks to Tesoro Foundation, South Texas Blood & Tissue Center can roll out new bus
9. Rockland Immunochemicals, Inc. Partners with Alex’s Lemonade Stand Foundation to Support Early Career Childhood Cancer Researchers
10. St. Baldricks Foundation Sets $50,000 Goal for Giving Tuesday Fundraising Challenge
11. Foundation for Food and Agriculture Research Opens Seeding Solutions Funding Opportunity: $7 Million Available for Bold Science Addressing Food and Agriculture Challenges
Post Your Comments:
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published in ... and fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched ... , After comparing the results from the fresh and frozen transfer cohorts, the ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ... of online age and identity verification solutions, announced today ... Identity Conference 2017, May 15 thru May 17, 2017, ... Building and International Trade Center. Identity ... globe and in today,s quickly evolving digital world, defining ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
Breaking Biology News(10 mins):